Spots Global Cancer Trial Database for cirrhosis
Every month we try and update this database with for cirrhosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma | NCT04499833 | Hepatocellular ... Recurrence Tumo... | liver transplan... | 18 Years - 70 Years | Centro Hospitalar de Lisboa Central | |
| Hepatocarcinoma Recurrence on the Liver Study - Part2 | NCT04053231 | Liver Cancer Surgery Recurrence Tumo... Cirrhosis | liver resection | 18 Years - | University of Milano Bicocca | |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis | NCT02151864 | Hepatocellular ... Cirrhosis | LDE225 | 18 Years - | University of California, San Diego | |
| Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis | NCT03407001 | Cirrhosis | Contrast-Enhanc... Sulfur Hexafluo... Ultrasound | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment | NCT01492127 | Hepatocellular ... Cirrhosis | Blood test | 18 Years - | University Hospital, Montpellier | |
| A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers | NCT02272504 | Cirrhosis Chronic Liver D... | 18 Years - | Wako Life Sciences | ||
| Project OASIS: Optimizing Approaches to Select Implementation Strategies | NCT06061328 | Cirrhosis Hepatocellular ... | OASIS DA traini... Current DA Tool... | 18 Years - | VA Office of Research and Development | |
| Volatile Organic Compounds for the Assessment of Liver Disease | NCT04620538 | Cirrhosis Cirrhosis, Live... Fibrosis, Liver Hepatocellular ... Hepatocellular ... | Breath Analysis | 18 Years - 90 Years | Imperial College London | |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | NCT02273362 | Cirrhosis Hepatocellular ... | Erlotinib Erlotinib Hydro... Laboratory Biom... Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | NCT02273362 | Cirrhosis Hepatocellular ... | Erlotinib Erlotinib Hydro... Laboratory Biom... Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
| Mesenchymal Stem Cells After Renal or Liver Transplantation | NCT01429038 | Liver Failure Kidney Failure | Mesenchymal Ste... | 18 Years - 75 Years | University of Liege | |
| Resection for Multiple Hepatocellular Carcinomas (HCC) | NCT01387061 | Hepatocellular ... Multiple Tumors Cirrhosis | hepatic resecti... | - | University of Milan | |
| Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer | NCT00151671 | Liver Cancer Hepatocellular ... Cirrhosis Liver Fibrosis | Oral Impact® Placebo | 18 Years - | Rennes University Hospital | |
| A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers | NCT02272504 | Cirrhosis Chronic Liver D... | 18 Years - | Wako Life Sciences | ||
| Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility | NCT03342677 | Hepatocellular ... | Primovist MRI | 18 Years - | University Health Network, Toronto | |
| Prospective Cohort for Early Detection of Liver Cancer | NCT05541601 | Cirrhosis Hepatocellular ... | Blood and Urine... | 18 Years - 100 Years | University of Oxford | |
| B-mode Ultrasound Imaging in Detecting Early Liver Cancer | NCT02774161 | Cirrhosis Early Hepatocel... Fibrosis Stage I Hepatoc... Stage II Hepato... | Ultrasound Tomo... | 18 Years - | Stanford University | |
| Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | NCT05635266 | Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo | Specimen sample | 18 Years - 85 Years | Sanguine Biosciences | |
| Microbiota Study in Liver Transplanted Patients | NCT03507140 | Cirrhosis Hepatocellular ... Liver Transplan... Microbiota | Multiple sampli... | 18 Years - 70 Years | University Hospital, Grenoble | |
| PROLIFICA - West African Treatment Cohort for Hepatitis B | NCT02129829 | Hepatitis B, Ch... Hepatocellular ... | Tenofovir disop... | 18 Years - | Imperial College London | |
| Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis | NCT05201404 | Hepatocellular ... Cirrhosis | Namodenoson Placebo | 18 Years - | Can-Fite BioPharma | |
| Mutational Landscape in Hepatocellular Carcinoma | NCT03071458 | HepatoCellular ... Cirrhosis | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study | NCT00629421 | Cirrhosis Hepatocellular ... | - | Kaohsiung Medical University Chung-Ho Memorial Hospital | ||
| CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection | NCT05433467 | Cirrhosis, Live... Hepatocellular ... | CT-guided local... | 18 Years - | Northern Jiangsu People's Hospital | |
| Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients | NCT01798173 | Cirrhosis With ... Cirrhosis Witho... | Serum, plasma a... Radiological ex... | 35 Years - | Centre Hospitalier Universitaire Dijon | |
| HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma | NCT04499833 | Hepatocellular ... Recurrence Tumo... | liver transplan... | 18 Years - 70 Years | Centro Hospitalar de Lisboa Central | |
| Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers | NCT04179773 | Cirrhosis Neoplasms | Current care st... | 18 Years - | University Hospital, Lille | |
| Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis | NCT03407001 | Cirrhosis | Contrast-Enhanc... Sulfur Hexafluo... Ultrasound | 18 Years - | M.D. Anderson Cancer Center | |
| Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI | NCT05486572 | Carcinoma, Hepa... Cirrhosis | Abbreviated Mag... Abdominal Ultra... | 18 Years - 75 Years | VA Office of Research and Development | |
| Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease | NCT01350167 | Cirrhosis End Stage Liver... Hepatitis C | Screening | 18 Years - | Minneapolis Veterans Affairs Medical Center | |
| Transient Elastography in Hepatectomy for Hepatocellular Carcinoma | NCT01441453 | Surgery Hepatocellular ... | FibroScan (Tran... | - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor | NCT00706576 | Hepatocellular ... | Infusion of opi... | 18 Years - | University of Missouri-Columbia | |
| Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | NCT01387503 | Carcinoma, Hepa... Cirrhosis | Liver transplan... | 18 Years - 65 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| Mesenchymal Stem Cells After Renal or Liver Transplantation | NCT01429038 | Liver Failure Kidney Failure | Mesenchymal Ste... | 18 Years - 75 Years | University of Liege | |
| Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L | NCT02232490 | Hepatocellular ... HCC Liver Cancer | hepcortespenlis... Placebo | 18 Years - | Immunitor LLC | |
| A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis | NCT06096779 | Hepatocellular ... | Atezolizumab Bevacizumab | 18 Years - | Genentech, Inc. | |
| Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis | NCT03853928 | Microbiota Hepatocellular ... Cirrhosis | Probiotics | 18 Years - | Austral University, Argentina | |
| Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors | NCT02143401 | Cirrhosis Hepatitis B Inf... Hepatitis C Inf... Metastatic Mali... Recurrent Hepat... Recurrent Malig... Refractory Mali... Stage IV Hepato... Unresectable So... | Laboratory Biom... Navitoclax Pharmacological... Sorafenib Sorafenib Tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis | NCT00190385 | Compensated Cir... | Ultrasonographi... | 30 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Transient Elastography in Hepatectomy for Hepatocellular Carcinoma | NCT01441453 | Surgery Hepatocellular ... | FibroScan (Tran... | - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Prospective Cohort for Early Detection of Liver Cancer | NCT05541601 | Cirrhosis Hepatocellular ... | Blood and Urine... | 18 Years - 100 Years | University of Oxford | |
| Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors | NCT02143401 | Cirrhosis Hepatitis B Inf... Hepatitis C Inf... Metastatic Mali... Recurrent Hepat... Recurrent Malig... Refractory Mali... Stage IV Hepato... Unresectable So... | Laboratory Biom... Navitoclax Pharmacological... Sorafenib Sorafenib Tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial | NCT02817685 | Chronic Hepatit... | 3 months 6 months 3 month ultraso... | 18 Years - 80 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers | NCT02272504 | Cirrhosis Chronic Liver D... | 18 Years - | Wako Life Sciences | ||
| Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid Analysis | NCT05797649 | Pleural Effusio... Heart Failure Malignant Neopl... Fluid Overload Hypoalbuminemia Renal Failure Cirrhosis Infections | 18 Years - | Chinese University of Hong Kong | ||
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | NCT02968810 | Cirrhosis Hepatocellular ... | Biospecimen Col... Computed Tomogr... Magnetic Resona... Placebo Adminis... Questionnaire A... Simvastatin | 18 Years - | National Cancer Institute (NCI) | |
| Adult-to-Adult Living Donor Liver Transplantation Study | NCT00096733 | Cirrhosis Hepatitis C Hepatocellular ... | 18 Years - | Arbor Research Collaborative for Health | ||
| Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease | NCT01350167 | Cirrhosis End Stage Liver... Hepatitis C | Screening | 18 Years - | Minneapolis Veterans Affairs Medical Center | |
| Use of the French Healthcare Insurance Database | NCT02983968 | Cirrhosis | Description of ... | 18 Years - 75 Years | Centre Hospitalier Universitaire, Amiens | |
| Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation | NCT03946852 | Liver Transplan... Ischemia Reperf... Cirrhosis Liver Cancer Liver Metastase... End Stage Liver... | Abdominal Regio... | 18 Years - 75 Years | London Health Sciences Centre | |
| Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis | NCT03407001 | Cirrhosis | Contrast-Enhanc... Sulfur Hexafluo... Ultrasound | 18 Years - | M.D. Anderson Cancer Center | |
| PROLIFICA - West African Treatment Cohort for Hepatitis B | NCT02129829 | Hepatitis B, Ch... Hepatocellular ... | Tenofovir disop... | 18 Years - | Imperial College London | |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | NCT01387503 | Carcinoma, Hepa... Cirrhosis | Liver transplan... | 18 Years - 65 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer | NCT02321202 | Liver Cancer Cirrhosis | Omega-3 Fatty A... Structolipid | 18 Years - 75 Years | Huazhong University of Science and Technology | |
| Characterization of Methylation Patterns in Hepatocellular Carcinoma | NCT04264754 | Hepatocellular ... Hepatocellular ... Cirrhosis | Blood collectio... | 22 Years - | Nucleix Ltd. | |
| Primary Prevention Hepatocellular Carcinoma by Metformin | NCT02319200 | Hepatocellular ... Hepatitis C, Ch... Cirrhosis | Metformin placebo tablet | 18 Years - 77 Years | Assistance Publique - Hôpitaux de Paris | |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis | NCT03278925 | Cirrhosis | Biopsy Biospecimen Col... Computed Tomogr... Defined Green T... Laboratory Biom... Magnetic Resona... Pharmacological... Questionnaire A... Ultrasound | 18 Years - | National Cancer Institute (NCI) | |
| Volatile Organic Compounds for the Assessment of Liver Disease | NCT04620538 | Cirrhosis Cirrhosis, Live... Fibrosis, Liver Hepatocellular ... Hepatocellular ... | Breath Analysis | 18 Years - 90 Years | Imperial College London | |
| Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid Analysis | NCT05797649 | Pleural Effusio... Heart Failure Malignant Neopl... Fluid Overload Hypoalbuminemia Renal Failure Cirrhosis Infections | 18 Years - | Chinese University of Hong Kong | ||
| Mutational Landscape in Hepatocellular Carcinoma | NCT03071458 | HepatoCellular ... Cirrhosis | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | ||
| CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection | NCT05433467 | Cirrhosis, Live... Hepatocellular ... | CT-guided local... | 18 Years - | Northern Jiangsu People's Hospital | |
| A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer | NCT06007846 | Hepatocellular ... Cirrhosis | Namenda | 18 Years - | Inova Health Care Services | |
| Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients | NCT04802954 | Hepatocellular ... Chronic Liver D... | Video acquisiti... | 18 Years - | IHU Strasbourg | |
| Microbiota Study in Liver Transplanted Patients | NCT03507140 | Cirrhosis Hepatocellular ... Liver Transplan... Microbiota | Multiple sampli... | 18 Years - 70 Years | University Hospital, Grenoble | |
| Validation of SMS Protocol for HCC Screening in High-risk Patients | NCT05429190 | Hepatocellular ... | Short MRI surve... Bi-annual ultra... | 18 Years - | Erasmus Medical Center | |
| B-mode Ultrasound Imaging in Detecting Early Liver Cancer | NCT02774161 | Cirrhosis Early Hepatocel... Fibrosis Stage I Hepatoc... Stage II Hepato... | Ultrasound Tomo... | 18 Years - | Stanford University | |
| Liver Resection Modeling | NCT04023136 | Benign Liver Tu... Malignant Tumor... Cirrhosis | partial hepatec... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients | NCT04802954 | Hepatocellular ... Chronic Liver D... | Video acquisiti... | 18 Years - | IHU Strasbourg | |
| A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making | NCT00122135 | Congestive Hear... Chronic Obstruc... Cirrhosis Colon Carcinoma Lung Cancer Chronic Kidney ... | Values Inventor... | 55 Years - | VA Office of Research and Development | |
| Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear Fluids | NCT03706846 | Cirrhosis | fasting | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients | NCT01669044 | Abdominal Tumor Intestinal Obst... Cirrhosis Intestinal Fist... Aneurism | dexmedetomidine propofol | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
| Microbiota Study in Liver Transplanted Patients | NCT03507140 | Cirrhosis Hepatocellular ... Liver Transplan... Microbiota | Multiple sampli... | 18 Years - 70 Years | University Hospital, Grenoble | |
| Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy | NCT01562821 | Acquired Bleedi... Cirrhosis | activated recom... activated recom... placebo | 21 Years - 70 Years | Novo Nordisk A/S | |
| Characterization of Methylation Patterns in Hepatocellular Carcinoma | NCT04264754 | Hepatocellular ... Hepatocellular ... Cirrhosis | Blood collectio... | 22 Years - | Nucleix Ltd. | |
| Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation | NCT02935478 | Obesity Weight Loss Body Weight Hepatocellular ... HCC Hepatitis C Cirrhosis | Embospheres Mic... | 18 Years - 65 Years | St. Louis University | |
| Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis | NCT03407001 | Cirrhosis | Contrast-Enhanc... Sulfur Hexafluo... Ultrasound | 18 Years - | M.D. Anderson Cancer Center | |
| Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis | NCT05181332 | Cirrhosis Biliary Atresia Choledochal Cys... Primary Scleros... HBV HCV Autoimmune Hepa... | Prediction mode... | 0 Years - 18 Years | West China Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
